F-1/A: Phaos Technology Holdings Appoints Key Executives, Eyes NYSE American Listing

Phaos Technology Holdings finalizes employment agreements and prepares for its initial public offering on the NYSE American.

Summary

• Phaos Technology Holdings (Cayman) Limited has formalized employment agreements with key executives: Beh Hook Seng (Executive Chairman), Gan Hong Loon (Chief Financial Officer), Andrew Yeo Eng Sian (Chief Executive Officer), and Tay Beng Boon (Chief Operations Officer).
• The agreements outline responsibilities, loyalty expectations, compensation details (referencing separate contracts with Phaos Technology Pte. Ltd.), and business expense reimbursements.
• The initial term of employment for each executive is set to end on March 14, 2026, with an automatic one-year extension unless either party provides written notice of non-renewal 30 days prior to the initial term's expiration.
• The agreements include clauses regarding confidential information, post-employment obligations, company property, non-competition, and non-solicitation of executives.
• Termination conditions are defined, covering death, permanent disability, termination for cause, without cause, or for good reason, including within 12 months following a change of control.
• The company is preparing for an initial public offering (IPO) of its Class A Ordinary Shares on the NYSE American, with the offering contingent upon listing approval.
• The preliminary prospectus indicates an anticipated IPO price between US$4.00 and US$5.00 per share.
• The company has granted the underwriter an option to purchase up to 405,000 additional Class A Ordinary Shares within 45 days from the closing date of the offering.
• Selling shareholders are offering an aggregate of 900,090 Ordinary Shares in the offering.
• Upon completion of the offering, the company expects to be a controlled company under NYSE American rules, with Beh Hook Seng controlling a majority of the voting power.
• The company is registered as an emerging growth company and a foreign private issuer, which allows for reduced reporting requirements.

Sentiment

Score: 7

Explanation: The document is generally positive, outlining the company's plans for growth and expansion. However, the mention of net losses and accumulated deficits tempers the overall sentiment.

Positives

• Formalized employment agreements provide clarity and stability for key executive roles.
• The IPO on the NYSE American could provide access to capital for growth and expansion.
• Being an emerging growth company and a foreign private issuer allows for reduced reporting requirements, potentially saving costs and resources.

Negatives

• The company expects to be a controlled company post-IPO, which could limit the influence of other shareholders.
• The company's financial statements indicate a net loss and accumulated deficit for October 31, 2024.

Risks

• The IPO is contingent upon listing approval from the NYSE American.
• The company will be a controlled company, which may limit the influence of other shareholders.
• The company's financial statements indicate a net loss and accumulated deficit for October 31, 2024.
• The preliminary prospectus contains forward-looking statements that involve risks and uncertainties.

Future Outlook

The company plans to strengthen its market position in Singapore and progressively expand into the Southeast Asian region. It also intends to run marketing and promotion campaigns, invest in product development, and expand its supply chain.

Industry Context

The announcement reflects a company positioning itself for growth in the advanced microscopy solutions market, a sector driven by technological innovation and increasing demand for high-precision measurement and magnification tools across various industries.

Comparison to Industry Standards

• The document does not provide enough information to make a detailed comparison to industry standards.
• However, the company's focus on super-resolution imaging and AI-powered software aligns with trends in the microscopy market.
• Keyence Corp. (TYO:6861), Nikon Corp. (TYO:7731), Olympus Corp. (TYO: 7733) and Hirox Co. Ltd are listed as competitors.

Related Party Transactions

• The Company received advances from major shareholder, TongHuai SG Enterprise Pte. Ltd. for business working purposes.
• The payable balance due to TongHuai SG Enterprise Pte. Ltd. was S$732,753 and S$1,145,423 (US$865,825) as of April 30, 2024 and October 31, 2024.
• Such balance is interest free, unsecured, and due on demand without an agreement.

Stakeholder Impact

• Shareholders: Potential for increased value through IPO and future growth.
• Employees: Continued employment and potential for career advancement.
• Customers: Access to innovative microscopy solutions.
• Suppliers: Continued business relationships and potential for increased orders.
• Creditors: Repayment of existing debt and potential for new financing opportunities.

Next Steps

• Obtain listing approval from the NYSE American.
• Execute the underwriting agreement.
• Complete the IPO and begin trading on the NYSE American.
• Implement business strategies for growth and expansion.

Key Dates

Keywords

IPO, employment agreement, Phaos Technology Holdings, NYSE American, executive compensation, corporate governance, emerging growth company, foreign private issuer, share offering, listing